---
title: "CMV in Pregnancy: Prevention, Screening Options, and Newborn Outcomes"
date: 2026-11-17T23:30:00-05:00
author: Shang Salamante
canonical_url: "https://www.americordblood.com/articles/cmv-in-pregnancy-prevention-screening-newborn-outcomes"
section: Articles
---
![Group b strep in pregnancy screening treatment and how it protects your newborn](https://assets.americordblood.com/transforms/blogs/7496000/group-b-strep-in-pregnancy-screening-treatment-and-how-it-protects-your-newborn_dcd4b851eab0fdc82c7554dc6e8ca81c.jpg)    [  Pregnancy &amp; Parenting  ](https://www.americordblood.com/articles/pregnancy-parenting) 

 7 Min Read 

 

# CMV in Pregnancy: Prevention, Screening Options, and Newborn Outcomes

Cytomegalovirus (CMV) is a common virus that can cause congenital infection when acquired during pregnancy, and about 1 in 200 U.S. babies is born with congenital CMV. Congenital CMV is a leading non-genetic cause of childhood hearing loss, yet prevention and screening are not routinely discussed in prenatal care.

This guide summarizes what CMV is, how it spreads, current recommendations on screening and diagnosis, practical prevention steps, breastfeeding considerations, and evidence-based treatments and follow-up for affected newborns.

## Key Takeaways

- About 1 in 200 babies is born with congenital CMV, and it is a leading non-genetic cause of childhood hearing loss.
- CMV most often spreads to pregnant people through contact with saliva or urine of young children and through sexual contact.
- Routine CMV blood screening in pregnancy is not recommended by major U.S. medical organizations due to limited benefit and potential for false positives.
- Newborn CMV must be confirmed by PCR testing of saliva or urine within the first 2–3 weeks of life to distinguish congenital from postnatal infection.
- For healthy term infants, breastfeeding is generally safe even when the mother is CMV-positive; extra precautions may be considered for very preterm or very low birth weight infants.
- Symptomatic congenital CMV may be treated with oral antivirals started in the first month of life and requires long-term hearing and developmental follow-up.

## What is cytomegalovirus (CMV), and why does it matter in pregnancy?

CMV is a common herpesvirus that usually causes mild or no illness in healthy people but can infect the fetus if a pregnant person is infected. Congenital CMV can lead to hearing loss and other disabilities, making it a key prenatal topic despite limited routine counseling.

Most adults will be infected with CMV at some point in their lives, and the virus then remains latent in the body. Congenital infection happens when the virus crosses the placenta during pregnancy, especially with a first (primary) infection, though reinfections and reactivations can also transmit CMV to the fetus.

## How common is congenital CMV, and how do pregnant people get it?

In the United States, about 1 in 200 babies (0.5%) is born with congenital CMV, and around 1 in 5 of those children will have long-term health problems such as hearing loss. Pregnant people most often acquire CMV through contact with saliva or urine from young children and through sexual contact.

The risk of CMV exposure is higher for those living with or caring for toddlers, especially in group childcare settings where CMV shedding is common. Simple behavior changes—like careful hand hygiene after diapering or wiping a child's nose—can lower risk.

## Should I be screened for CMV before or during pregnancy?

Routine blood screening for CMV before or during pregnancy is not recommended by major U.S. groups because test interpretation is complex and there is no universally accepted intervention that improves outcomes after a positive screen. Targeted testing may be considered after a concerning exposure, symptoms suggestive of CMV, or specific ultrasound findings.

CMV IgM can be falsely positive or reflect past infection, and isolated IgM positivity should not be used to diagnose a new infection without confirmatory testing. If testing is pursued, clinicians may use paired CMV IgG tests for seroconversion and IgG avidity to help determine timing of infection.

- When screening may be considered: new mononucleosis-like illness in pregnancy, a documented high-risk exposure, or abnormal fetal imaging.
- When routine screening is not recommended: asymptomatic patients without specific risk factors or imaging concerns.

## How is CMV infection diagnosed in mothers and babies?

In pregnancy, recent CMV infection is suggested by new CMV IgG seroconversion or low-avidity IgG, often with or without IgM, and fetal infection can be confirmed by CMV PCR testing of amniotic fluid. In newborns, congenital CMV is diagnosed by PCR testing of saliva or urine within the first 2–3 weeks of life.

TestWho/What is testedBest timingWhat it tells youKey limitationsCMV IgG and IgM serologyPregnant personAnytime; paired tests 2–3 weeks apart if neededIgG shows past exposure; new IgG or rising titers suggest recent infection; IgM may suggest recent infectionIgM has false positives and can persist; results need expert interpretationIgG avidityPregnant personEarly after suspected infectionLow avidity supports recent primary infection; high avidity supports past infectionDoes not prove fetal infection; interpretation depends on timingAmniocentesis with CMV PCRAmniotic fluidTypically in the second trimester after maternal infection is suspectedConfirms fetal CMV infection if positiveNegative result does not fully exclude infection if done too early; invasive procedureSaliva or urine CMV PCRNewbornWithin 2–3 weeks after birthDiagnoses congenital CMV if positive in this windowAfter 3 weeks, a positive result may reflect postnatal acquisitionDried blood spot CMV PCRNewborn screening card (retrospective)After birth (often retrospective)Can help confirm congenital CMV when availableLower sensitivity than saliva/urine PCR; not universally available

## What pregnancy or ultrasound findings raise concern for congenital CMV?

Ultrasound findings that may prompt CMV evaluation include fetal growth restriction, cerebral ventriculomegaly, intracranial calcifications, echogenic bowel, hepatosplenomegaly, ascites, hydrops, and microcephaly. These findings are not specific to CMV, so targeted lab testing and, when appropriate, amniocentesis are used to clarify the diagnosis.

- Central nervous system: ventriculomegaly, periventricular calcifications, microcephaly.
- Abdominal: echogenic bowel, hepatosplenomegaly, ascites.
- Other: hydrops fetalis, placentomegaly, fetal growth restriction.

## What practical steps can reduce my CMV risk if I have close contact with young children?

The most effective strategies are consistent hand hygiene and avoiding contact with saliva and urine from young children. Avoid sharing food, utensils, drinks, or toothbrushes with toddlers and kiss children on the head rather than the mouth.

- Wash hands with soap and water for at least 20 seconds after diaper changes, wiping noses, feeding, or handling toys.
- Do not share cups, utensils, food, or toothbrushes with young children.
- Avoid kissing children on the lips; opt for the top of the head.
- Clean high-touch surfaces and toys regularly.
- Use condoms with new sexual partners to reduce sexual transmission.
- There is currently no licensed CMV vaccine.

## Is breastfeeding safe if I’m CMV-positive, and does timing or prematurity change the guidance?

For healthy full-term infants, breastfeeding is generally recommended even when a mother is CMV-positive, because postnatal CMV from breast milk is usually mild or asymptomatic in term babies. For very preterm or very low birth weight infants, units may consider risk-reduction strategies such as pasteurization or freezing of expressed milk depending on clinical status and local protocols.

CMV can be present in breast milk, and the risk of symptomatic postnatal infection is greatest for very preterm infants. Freezing can lower, and pasteurization can inactivate, CMV in milk but may alter some milk components; decisions should be individualized with the neonatal team.

## If my baby has congenital CMV, what treatments and follow-up care are recommended?

Babies with symptomatic congenital CMV should be promptly evaluated by specialists, and antiviral therapy (often oral valganciclovir) started within the first month of life may improve hearing and developmental outcomes in selected cases. All infants with congenital CMV need ongoing hearing assessments through early childhood and developmental follow-up with early intervention as needed.

- Initial evaluation: confirmatory PCR testing, thorough physical exam, hearing (ABR), ophthalmology exam, liver function and blood counts, and neuroimaging as indicated.
- Antiviral therapy: valganciclovir is typically considered for symptomatic infants under infectious disease guidance; therapy duration is commonly 6 months in selected cases.
- Hearing follow-up: regular audiology evaluations since hearing loss can be late-onset or progressive.
- Developmental care: early intervention, physical/occupational/speech therapies as needed.
- Care team: pediatric infectious disease, audiology, ophthalmology, neurology as indicated, and primary care for routine monitoring.

## Frequently Asked Questions

### Can I get CMV again if I’ve had it before?

Yes. After a first infection, CMV stays dormant and can reactivate, and people can also be reinfected with a different CMV strain. Prior immunity may lower but does not eliminate the risk of transmitting CMV to a fetus.

### Does a positive CMV IgM always mean a new infection?

No. CMV IgM can appear with reactivation or persist after prior infection and can be falsely positive. Diagnosing a recent primary infection usually requires additional testing such as IgG seroconversion or IgG avidity.

### Will a C-section prevent CMV transmission to my baby?

No. Congenital CMV is acquired before birth via the placenta, so delivery method does not prevent congenital infection. Most postnatal CMV in term infants is mild even with vaginal delivery and breastfeeding.

### Is there a vaccine to prevent CMV?

There is no licensed CMV vaccine available yet. Vaccine research is ongoing, so prevention currently relies on hygiene and behavioral measures.

### Should my older children be tested for CMV?

Routine CMV testing of healthy older children is not recommended. Focus on practical hygiene steps to reduce exposure during pregnancy regardless of a child’s CMV status.

### If my newborn fails the hearing screen, should they be tested for CMV?

Many programs consider targeted CMV testing for infants who fail the newborn hearing screen because early diagnosis can guide monitoring and therapy. Testing must occur within 2–3 weeks of birth to confirm congenital CMV.

## Sources

1. CDC — [Cytomegalovirus (CMV) and Congenital CMV Infection](https://www.cdc.gov/cmv/index.html)
2. NIDCD (NIH) — [Congenital Cytomegalovirus (CMV) and Hearing Loss](https://www.nidcd.nih.gov/health/congenital-cytomegalovirus-and-hearing-loss)
3. ACOG — [Cytomegalovirus (CMV) in Pregnancy](https://www.acog.org/womens-health/faqs/cytomegalovirus-in-pregnancy)
4. CDC — [Breastfeeding and CMV Infection: Special Circumstances](https://www.cdc.gov/breastfeeding/breastfeeding-special-circumstances/maternal-or-infant-illnesses/cytomegalovirus.html)
5. The New England Journal of Medicine (PubMed) — [Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease](https://pubmed.ncbi.nlm.nih.gov/26544743/)
6. The Lancet Infectious Diseases (PubMed) — [Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations](https://pubmed.ncbi.nlm.nih.gov/28643124/)
7. MedlinePlus (NIH) — [Cytomegalovirus Infections](https://medlineplus.gov/cytomegalovirusinfections.html)

*The views, statements, and pricing expressed are deemed reliable as of the published date. Articles may not reflect current pricing, offerings, or recent innovations.*

 

  

### Complete Family Plan

Perfect for families who believe in the frontier of modern and regenerative medicine.

 [ View Service ](https://www.americordblood.com/complete-family-plan) 

### Simple, Straight Forward Pricing

At Americord, we provide the highest-quality stem cell processing and the lowest storage rates in the industry. Discover which payment plan is best for you!

 [ View Service ](https://www.americordblood.com/pricing) 

### Be the First to Know

Never miss the latest cord blood breakthrough, clinical trial, or stem cell education to keep your family healthy for life.

  Sign Up  

    

  

 

 

 

 

 Share [  ](https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.americordblood.com%2Farticles%2Fcmv-in-pregnancy-prevention-screening-newborn-outcomes "Facebook") [  ](https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fwww.americordblood.com%2Farticles%2Fcmv-in-pregnancy-prevention-screening-newborn-outcomes "LinkedIn") [  ](mailto:?body=https%3A%2F%2Fwww.americordblood.com%2Farticles%2Fcmv-in-pregnancy-prevention-screening-newborn-outcomes "Email") 

 

  

## Related Articles

 [    ![Newborn hearing screening 101 oae vs abr what results mean and when to follow up](https://assets.americordblood.com/transforms/blogs/7495963/newborn-hearing-screening-101-oae-vs-abr-what-results-mean-and-when-to-follow-up_41a4f2ed037c5ad51696884668d44cc6.jpg)  ](https://www.americordblood.com/articles/newborn-hearing-screening-oae-abr-results-follow-up) [### Newborn Hearing Screening 101: OAE vs. ABR, What Results Mean, and When to Follow Up

 ](https://www.americordblood.com/articles/newborn-hearing-screening-oae-abr-results-follow-up)

Understand newborn hearing screening: OAE vs. ABR, what pass/refer mean, timelines for follow-up, key risk factors, and how early care supports language.

 

 [ Read More ](https://www.americordblood.com/articles/newborn-hearing-screening-oae-abr-results-follow-up) 

 

 [    ![6a735194a5e4d9396b8a0ca6 1785944209735](https://assets.americordblood.com/transforms/blogs/6409410/6a735194a5e4d9396b8a0ca6-1785944209735_2026-08-06-154930_meqh_41a4f2ed037c5ad51696884668d44cc6.jpg)  ](https://www.americordblood.com/articles/sickness-in-the-house-protecting-your-pregnancy-from-school-aged-bugs) [### Sickness in the House: Protecting Your Pregnancy from School-Aged Bugs

 ](https://www.americordblood.com/articles/sickness-in-the-house-protecting-your-pregnancy-from-school-aged-bugs)

Simple, practical steps to lower infection risk during pregnancy when school-aged kids bring home bugs.

 

 [ Read More ](https://www.americordblood.com/articles/sickness-in-the-house-protecting-your-pregnancy-from-school-aged-bugs) 

 

 [    ![Doctor pointing at medical icon with stethoscope in hand.](https://assets.americordblood.com/transforms/blogs/6224/12-illnesses-newborn-health-screening-americord_41a4f2ed037c5ad51696884668d44cc6.png)  ](https://www.americordblood.com/articles/the-power-of-early-detection-12-illnesses-newborn-health-screening-tests-for) [### The Power of Early Detection: 12 Illnesses Newborn Health Screening Tests For

 ](https://www.americordblood.com/articles/the-power-of-early-detection-12-illnesses-newborn-health-screening-tests-for)

Safeguarding a baby's health comes down to early detection and diagnosis of any potential health issues. myNewborn Health Screening does just that.

 

 [ Read More ](https://www.americordblood.com/articles/the-power-of-early-detection-12-illnesses-newborn-health-screening-tests-for)
